4.7 Article

Biomarker responses to folic acid intervention in healthy adults: a meta-analysis of randomized controlled trials

Journal

AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume 99, Issue 1, Pages 96-106

Publisher

ELSEVIER SCIENCE INC
DOI: 10.3945/ajcn.113.062752

Keywords

-

Funding

  1. Commission of the European Communities, RTD Programme Quality of Life and Management of Living Resources, within the 6th Framework Programme [FP6-036196-2 EURRECA]
  2. Biotechnology and Biological Sciences Research Council [BBS/E/F/00044435, BBS/E/F/00042669] Funding Source: researchfish
  3. BBSRC [BBS/E/F/00044435, BBS/E/F/00042669] Funding Source: UKRI

Ask authors/readers for more resources

Background: The task of revising dietary folate recommendations for optimal health is complicated by a lack of data quantifying the biomarker response that reliably reflects a given folate intake. Objective: We conducted a dose-response meta-analysis in healthy adults to quantify the typical response of recognized folate biomarkers to a change in folic acid intake. Design: Electronic and bibliographic searches identified 19 randomized controlled trials that supplemented with folic acid and measured folate biomarkers before and after the intervention in apparently healthy adults aged >= 18 y. For each biomarker response, the regression coefficient (beta) for individual studies and the overall pooled beta were calculated by using random-effects meta-analysis. Results: Folate biomarkers (serum/plasma and red blood cell folate) increased in response to folic acid in a dose-response manner only up to an intake of 400 mu g/d. Calculation of the overall pooled beta for studies in the range of 50 to 400 mu g/d indicated that a doubling of folic acid intake resulted in an increase in serum/plasma folate by 63% (71% for microbiological assay; 61% for nonmicrobiological assay) and red blood cell folate by 31% (irrespective of whether microbiological or other assay was used). Studies that used the microbiological assay indicated lower heterogeneity compared with studies using nonmicrobiological assays for determining serum/plasma (I-2 = 13.5% compared with I-2 = 77.2%) and red blood cell (I-2 = 45.9% compared with I-2 = 70.2%) folate. Conclusions: Studies administering >400 mu g folic acid/d show no dose-response relation and thus will not yield meaningful results for consideration when generating dietary folate recommendations. The calculated folate biomarker response to a given folic acid intake may be more robust with the use of a microbiological assay rather than alternative methods for blood folate measurement.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available